Hologic (HOLX) Tops Q1 EPS by 2c, provides guidance
Hologic (NASDAQ: HOLX) reported Q1 EPS of $1.03, $0.02 better than the analyst estimate of $1.01. Revenue for the quarter came in at $1.02 billion versus the consensus estimate of $1.03 billion.
GUIDANCE:
Hologic sees Q2 2025 EPS of $1.00-$1.03, versus the consensus of $1.04. Hologic sees Q2 2025 revenue of $0.995-1.005 billion, versus the consensus of $1.033 billion.
Hologic sees FY2025 EPS of $4.25-$4.35, versus the consensus of $4.25. Hologic sees FY2025 revenue of $4.05-4.1 billion, versus the consensus of $4.155 billion.
For earnings history and earnings-related data on Hologic (HOLX) click here.
